Filing Flows › bioAffinity Technologies (BIAF) › How it makes money
How bioAffinity Technologies (BIAF) makes money
bioAffinity Technologies (BIAF) made $1.1M of revenue in the third quarter 2026 (Q3 2026), -26% from a year earlier. Health Care, Patient Service brought in $863K (81%); Histology Service Fees brought in $190K (18%); Medical Director Fees brought in $17K (2%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Health Care, Patient Service | $863K | 80.7% | -31% | -26% |
| Histology Service Fees | $190K | 17.7% | -24% | -26% |
| Medical Director Fees | $17K | 1.6% | -2% | -0.4% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $1.1M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $1.1M | -26% |
| Q2 2026 | $1.5M | +19% |
| Q1 2026 | $1.4M | -27% |
| Q4 2025 | $1.6M | -28% |
| Q3 2025 | $1.4M | -38% |
| Q2 2025 | $1.3M | -47% |
| Q1 2025 | $1.9M | -23% |
From bioAffinity Technologies' 10-Q filed Nov 6, 2026 (on EDGAR).
Questions
How does bioAffinity Technologies make money?
bioAffinity Technologies (BIAF) made $1.1M of revenue in the third quarter 2026 (Q3 2026), -26% from a year earlier. Health Care, Patient Service brought in $863K (81%); Histology Service Fees brought in $190K (18%); Medical Director Fees brought in $17K (2%).
What is bioAffinity Technologies' biggest business?
Health Care, Patient Service: $863K in the third quarter 2026, 81% of revenue, -26% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.